Tenecteplase biosimilar (Hetero Biopharma)

N/A

Report date: 2025/01/16 15:10:46

Base Information

Drug NameTenecteplase biosimilar (Hetero Biopharma)

Drug Alias NameN/A

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionPlasminogen activators

TargetsPlasminogen

Therapy Area/IndicationsST Elevation Myocardial Infarction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesHetero Biopharma Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHetero Biopharma Ltd

Inactive CompaniesN/A

Active IndicationsST Elevation Myocardial Infarction

Inactive IndicationsN/A

Other Information

ATC CodeN/A